Eric Tonnar

Eric Tonnar is an accomplished sales executive with extensive experience in the pharmaceutical industry. Currently serving as Area Sales Director at Phathom Pharmaceuticals since September 2022, Tonnar has previously held significant leadership roles including National Sales Director at Greenwich Biosciences, where Tonnar led the commercialization of the first FDA-approved plant-derived cannabinoid therapy, EPIDIOLEX®, achieving successful launch in November 2018. Prior to that, Tonnar held the position of Director of Sales at Kate Farms, leading a national sales team in the medical nutrition sector. Additional experience includes Senior Regional Sales Manager roles at Allergan and Aptalis, where Tonnar consistently drove market share growth and led top-performing teams. Tonnar holds a Bachelor's degree in Marketing from the University of Minnesota Duluth.